Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2002-09-20
2009-08-11
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S247000, C514S256000, C514S228800, C514S231500, C514S235500, C544S063000, C544S098000, C544S106000, C544S111000, C544S149000, C544S224000, C544S242000, C544S295000, C544S296000
Reexamination Certificate
active
07572793
ABSTRACT:
A pyrimidone derivative represented by formula (I) or a salt thereof, or a solvate thereof or a hydrate thereof having inhibitory activity against tau protein kinase 1:wherein R1represents a C1-C12alkyl group which may be substituted;R represents, for example, a group represented by the following formula (II):wherein R2and R3independently represent a hydrogen atom or a C1-C8alkyl group;R4represents a benzene ring which may be substituted, a naphthalene ring which may be substituted, an indan ring which may be substituted, a tetrahydronaphthalene ring which may be substituted, or an optionally substituted heterocyclic ring having 1 to 4 hetero atoms selected from the group consisting of oxygen atom, sulfur atom and nitrogen atom, and having 5 to 10 ring-constituting atoms in total.
REFERENCES:
patent: 4166180 (1979-08-01), Kato et al.
patent: 4507302 (1985-03-01), Fast et al.
patent: 4619933 (1986-10-01), Stringfellow et al.
patent: 4725600 (1988-02-01), Takaya et al.
patent: 5612286 (1997-03-01), Mayer et al.
patent: 6096753 (2000-08-01), Spohr et al.
patent: 6107301 (2000-08-01), Aldrich et al.
patent: 6410729 (2002-06-01), Spohr et al.
patent: 6420385 (2002-07-01), Spohr et al.
patent: 6586441 (2003-07-01), Borroni et al.
patent: 6844335 (2005-01-01), Almario Garcia et al.
patent: 2003/0187004 (2003-10-01), Almario Garcia et al.
patent: 2005/0090490 (2005-04-01), Uehara et al.
patent: 2005/0130998 (2005-06-01), Almario Garcia et al.
patent: 2006/0252768 (2006-11-01), Watanabe et al.
patent: 0168262 (1986-01-01), None
patent: 0354179 (1989-07-01), None
patent: 1136482 (2001-09-01), None
patent: 218974 (2001-01-01), None
patent: P 0001698 (2001-04-01), None
patent: 49-035631 (1974-04-01), None
patent: 49-35632 (1974-04-01), None
patent: 49-035633 (1974-04-01), None
patent: 49-35634 (1974-04-01), None
patent: 49-35631 (1974-09-01), None
patent: 49-35632 (1974-09-01), None
patent: 49-35633 (1974-09-01), None
patent: 49-35634 (1974-09-01), None
patent: 52-071481 (1977-06-01), None
patent: 52 139085 (1977-11-01), None
patent: 6 239893 (1994-08-01), None
patent: 6-329551 (1994-11-01), None
patent: 93/11231 (1998-06-01), None
patent: 98/24780 (1998-06-01), None
patent: 98 24782 (1998-06-01), None
patent: 98/24782 (1998-06-01), None
patent: 00-18758 (2000-04-01), None
patent: 00/18758 (2000-04-01), None
patent: 01/70728 (2001-09-01), None
patent: 01/70729 (2001-09-01), None
patent: 03/037888 (2003-05-01), None
patent: 2004/055007 (2004-07-01), None
patent: 2004/085408 (2004-10-01), None
Taguchi, Chemistry Letters, pp. 273-274, 1978 (3).
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
U.S. Appl. No. 10/538,766, filed Dec. 12, 2003 to Usui et al.
Anthony R. West, Solid State Chemistry and Its Applications, Wiley, New York, 1988 pp. 358 and 365.
Sudha R. Vippagunta et al., “Crystalline Solids”, Advance Drug Delivery Reviews, vol. 48, pp. 3-26 (2001).
Tani et al., CAPLUS Abstract 84:44112 (1976).
Joachim Ulrich, Chapter 4: Crystallization, Krik-Othmer Encyclopedia of Chemical Technology (Aug. 2002).
G. Glenner et al., Biochemical and Biophysical Research Communications, vol. 120, No. 3, 1984, pp. 885-890.
C.L. Masters et al., The EMBO Journal, vol. 4, No. 11, 1985, pp. 2757-2763.
C.L. Masters et al., Proc. Natl. Acad. Sci. USA, vol. 82, Jun. 1985, pp. 4245-4249.
C.M. Wischik et al., Proc. Natl. Acad. Sci. USA, vol. 85, Jun. 1988, pp. 4506-4510.
J. Kondo et al., Neuron, vol. 1, Nov. 1988, pp. 827-834.
R. Sherrington et al., Nature, vol. 375, Jun. 29, 1995, pp. 754-760.
E. Levy-Lahad et al., Science, vol. 269, Aug. 18, 1995, pp. 973-977.
E.I. Rogaev et al., Nature, vol. 376, Aug. 31, 1995, pp. 775-778.
D.R. Borchelt et al., Neuron, vol. 17, Nov. 1996, pp. 1005-1013.
T. Tomita et al., Proc. Natl. Acad. Sci. USA, vol. 94, Mar. 1997, pp. 2025-2030.
Y. Ihara et al., J. Biochem., vol. 99, 1986, pp. 1807-1810.
I. Grundke-Iqbal et al., Proc. Natl. Acad. Sci. USA, vol. 83, Jul. 1986, pp. 4913-4917.
K. Ishiguro et al., J. Biol. Chem., vol. 267, No. 15, May 25, 1992, pp. 10897-10901.
K. Ishiguro et al., FEBS Lett., vol. 325, Jul. 1993, pp. 167-172.
English Language Abstract of JP 6-239893, Date Publication Aug. 30, 1994.
B.A. Yankner et al., Science, vol. 250, 1990, pp. 279-283.
A. Takashima et al., Proc. Natl. Acad. Sci. USA, vol. 90, Aug. 1993, pp. 7789-7793.
H. Yinglin, Tetrahedron Letters, vol. 30, No. 39, 1989, pp. 5285-5286.
English language Abstract of JP 6-329551 Date Publication Nov. 29, 1994.
H. Yinglin, Synthesis, pp. 122-124, Feb. 1990.
R.L. Duncan Jr. et al., J. Med. Chem., vol. 13, No. 1, Jan. 1970, pp. 1-6.
D.L. Thai et al., J. Med. Chem., vol. 41, 1998, pp. 591-601.
Chemical Abstracts, vol. 100, No. 28, 1984, Columbus, Ohio, US, Abstract No. 174768e, M.F. Brana et al., “Reaction of N-(1-Oxido-4-Pyridylmethyl)-3,5-Dimethylbenzamide with Malononitrile in Acetic Anhydride”, p. 627; XP002127059.
Chemical Abstracts, vol. 84, No. 7, 1976, Columbus, Ohio, US, Abstract No. 44112b, Tani et al., “4-Hydroxy-Pyridylpyrimidine Derivatives”, p. 502, XP002127060.
Chemical Abstracts, vol. 82, No. 28, 1975, Columbus, Ohio, US, Abstract No. 171028n, Tani et al., “2,4,5-Trisubstituted-6-Pyridylpyrimidine Derivatives”, p. 555, XP002127061.
Chemical Abstracts, vol. 83, No. 28, 1975, Columbus, Ohio, US, Abstract No. 10127z, Tani et al., “5-Nitro-6-Pyridylpyrimidine Derivatives”, p. 853, XP002127062.
Chemical Abstract 1992, vol. 116, Abstract #59167.
Chemical Abstract 1966, vol. 65, Abstact #90645.
Von Hans-Joachim Kabbe, “Substituierte 4-Hydroxy- und 4-Amino-Pyrimidine”, Liebigs. Ann. Chem., vol. 701, pp. 144-149 (1967).
Harvey I. Skulnick et al., “Pyrimidinones. 1. 2-Amino-5-Halo-6-Arly-4(3H)-Pyrimidinones. Interferon-Inducing Antiviral Agents”, J. Med. Chem., vol. 28, pp. 1864-1869 (1985).
U.S. Appl. No. 09/787,426, filed Jul. 2, 2001 to Watanabe et al.
English language Abstract of JP 52-071481, Date Publication Jun. 14, 1977.
G. Glenner et al., Biochemical and Biophysical Research Communications, vol. 120, No. 3, 1984, pp. 885-890.
C.L. Masters et al., The EMBO Journal, vol. 4, No. 11, 1985, pp. 2757-2763.
C.L. Masters et al., Proc. Natl. Acad. Sci. USA, vol. 82, Jun. 1985, pp. 4245-4249.
C.M. Wischik et al., Proc. Natl. Acad. Sci. USA, vol. 85, Jun. 1988, pp. 4506-4510.
T. Tomita et al., Proc. Natl. Acad. Sci. USA, vol. 94, Mar. 1997, pp. 2025-2030.
Sai-Shin Igaku, vol. 49, No. 9, 1994, pp. 1506-1512.
D.W. Dickson et al., Society for Neuroscience Abstracts, vol. 17, 1991, pp. 1445.
R. Siman et al., The Journal of Neuroscience, vol. 10, No. 7, Jul. 1990, pp. 2400-2411.
Shin-kei Shinpo, vol. 34, 1990, pp. 343-349.
Tanpaku-shitu Kaku-san Koso, vol. 41, 1996, pp. 1476-1483.
Tanpaku-shitu Kaku-san Koso, vol. 36, 1991, pp. 2-11.
Igaku no Ayumi, vol. 158, No. 9, Aug. 31, 1991, pp. 511-514.
I Grundke-Iqbal et al., Proc. Natl. Acad. Sci. USA, vol. 83, Jul. 1986, pp. 4913-4917.
Seikagaku, vol. 64, No. 5, pp. 308-312.
K. Ishiguro et al., J. Biol. Chem., vol. 267, No. 15, May 25, 1992, pp. 10897-10901.
A. Takashima et al., Proc. Natl. Acad. Sci. USA, vol. 90, Aug. 1993, pp. 7789-7793.
Chemical Abstracts, vol. 100, No. 28, 1984, Columbus, Ohio, US, Abstract No. 174768e, M.F. Brana et al., “Reaction of N-(1-Oxido-4-Pyridylmethyl)-3,5-Dimethylbenzamide with Malononitrile in Acetic Anhydride”, p. 627; XP002127059.
Chemical Abstracts, vol. 84, No. 7, 1976, Columbus, Ohio, US, Abstract No. 44112b, Tani et al., “4-Hydroxy-Pyridylpyrimidine Derivatives”, p. 502, XP002127060.
Chemical Abstracts, vol. 82, No. 28, 1975, Columbus, Ohio, US, Abstract No. 171028n, Tani et al., “2,4,5-Trisubstituted-6-Pyridylpyrimidine Derivatives”, p. 555, XP002127061.
Chemical Abstracts, vol. 83, No. 28, 1975, Columbus, Ohio, US, Abstract No. 10127z, Tani et al., “5-Nitro-6-Pyridylpyrimidine Derivatives”, p. 853, XP002127062.
Von Hans-Joachim Kabbe, “Substituierte 4-Hydroxy- und 4-Amino-Pyrimidine”, Liebigs. Ann. Chem., vol. 701, pp. 144-149 (1967).
Harvey
Aritomo Keiichi
Hiki Shinsuke
Okuyama Masahiro
Ooizumi Mitsuru
Shoda Aya
Greenblum & Bernstein P.L.C.
Mitsubishi Tanabe Pharma Corporation
Saeed Kamal A
Sanofi-Aventis
Shterengarts Samantha L
LandOfFree
3-Substituted-4-pyrimidone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-Substituted-4-pyrimidone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-Substituted-4-pyrimidone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4138745